Evidence map›Paper›PMID 28218227›Full record

ArticleChinese medical journal2017

P190

Hua Wang, Zhi-Yong Wang, Chun-Hong Xin, Ying-Hui Shang, Rui Jing, Fa-Hong Yan, Si-Zhou Feng

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Chinese medical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Hua WangDepartment of Hematology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 264100, China.
Zhi-Yong WangDepartment of Hematology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 264100, China.
Chun-Hong XinDepartment of Hematology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 264100, China.
Ying-Hui ShangDepartment of Hematology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 264100, China.
Rui JingDepartment of Hematology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 264100, China.
Fa-Hong YanDepartment of Hematology, Weifang People's Hospital, Weifang, Shandong 261000, China.
Si-Zhou FengStem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
Binzhou University · CNBinzhou Medical University · CNInstitute of Hematology & Blood Diseases Hospital · CNWeifang People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaAgedAntineoplastic AgentsFusion Proteins, bcr-ablHumansLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMaleOrganoplatinum CompoundsOxaliplatinStomach NeoplasmsAntineoplastic AgentsFusion Proteins, bcr-ablOrganoplatinum CompoundsOxaliplatin

Identifiers

PMID28218227
PMCPMC5324390
OpenAlexW2587324843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.